Fusions with cd8 antigen binding molecules for modulating immune cell function
US-2024417470-A1 · Dec 19, 2024 · US
against CD8
against CD8 · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K16/2815 |
| Official title | {against CD8} |
| Display label | against CD8 |
| Total patents | 308 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is stable.
| Year | Patents |
|---|---|
| 2015 | 8 |
| 2016 | 14 |
| 2017 | 14 |
| 2018 | 19 |
| 2019 | 40 |
| 2020 | 24 |
| 2021 | 30 |
| 2022 | 41 |
| 2023 | 37 |
| 2024 | 38 |
| 2025 | 33 |
| 2026 | 10 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Biomarkers for cancer immunotherapy
US-11858994-B2 · Jan 2, 2024 · US
Immune response modifier conjugates
US-10472420-B2 · Nov 12, 2019 · US
Mucin-associated surface protein as a vaccine against chagas disease
US-10279023-B2 · May 7, 2019 · US
Cell
US-2019023761-A1 · Jan 24, 2019 · US
Methods of identifying immune cells in pd-l1 positive tumor tissue
US-2018372747-A1 · Dec 27, 2018 · US
Immune cell-targeted particles
US-2018369407-A1 · Dec 27, 2018 · US
Modified chimeric receptors and related compositions and methods
US-2018355014-A1 · Dec 13, 2018 · US
Il-2rbeta-selective agonists in combination with an anti-ctla-4 antibody or an anti-pd-1 antibody
US-2018344810-A1 · Dec 6, 2018 · US
Selective immunodepletion of endogenous stem cell niche for engraftment
US-2018327507-A1 · Nov 15, 2018 · US
Selective immunodepletion of endogenous stem cell niche for engraftment
US-10072091-B2 · Sep 11, 2018 · US
An Agent Capable of Depleting CD8 T Cells for the Treatment of Myocardial Infarction or Acute Myocardial Infarction
US-2018251552-A1 · Sep 6, 2018 · US
Methods and compositions for determining the potency of a therapeutic cellular composition
US-2018252729-A1 · Sep 6, 2018 · US
Near infrared photoimmunotherapy (nir-pit) of suppressor cells to treat cancer
US-2018236076-A1 · Aug 23, 2018 · US
Methods and compositions involving NKG2D inhibitors and cancer
US-10040853-B2 · Aug 7, 2018 · US
Methods of transplantation and disease treatment
US-2018200300-A1 · Jul 19, 2018 · US
IL-2Rβ-selective agonists in combination with an anti-CTLA-4 antibody or an anti-PD-1 antibody
US-10010587-B2 · Jul 3, 2018 · US
High throughput optimization of content-loaded nanoparticles
US-2018148714-A1 · May 31, 2018 · US
Nanoparticle conjugates and uses thereof
US-2018133343-A1 · May 17, 2018 · US
Therapeutic use of anti-CD22 antibodies for inducing trogocytosis
US-9963507-B2 · May 8, 2018 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K16/2815?
- CPC C07K16/2815 is the Cooperative Patent Classification code for “against CD8.”
- How many patents are filed under CPC C07K16/2815 (against CD8)?
- Our database includes 308 publications tagged with this CPC code.
- Is patent activity under CPC C07K16/2815 growing?
- Publication counts under this code: 38 in 2024 vs 33 in 2025 (latest complete years).